Pharmaceutical labs commit significant capital to acquiring cutting-edge equipment. However, these complex instruments often sit unused, resulting in a substantial financial burden. Underutilized equipment represents a loss ofresources and can negatively affect a lab's throughput. Quantifying the extent of this financial impact is essential for imp